Extracellular matrix in development of the intervertebral disc

Matrix Biology

Volumn 20, Issue 2, 2001, Pages 107-121

  Hayes, A J ^a   Benjamin, M ^a   Ralphs, J R ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Connective tissue; Development; Intervertebral disc; Spine

Indexed keywords

AGGRECAN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 4; FIBROMODULIN; FIBRONECTIN; GLYCOSAMINOGLYCAN; KERATAN SULFATE; LAMININ; LUMICAN; PROTEOGLYCAN; SCLEROPROTEIN; VERSICAN;

ANNULUS FIBROSUS; ARTICLE; CARTILAGE; CELL DIFFERENTIATION; COLLAGEN SYNTHESIS; COMPRESSION; CONNECTIVE TISSUE; CONTROLLED STUDY; DEVELOPMENT; EXTRACELLULAR MATRIX; FETUS; FIBROBLAST; GRAVITY; INTERVERTEBRAL DISK; MORPHOGENESIS; MYOBLAST; NEWBORN; NONHUMAN; NUCLEUS PULPOSUS; PRIORITY JOURNAL; RAT; SPINE; TISSUE DISTRIBUTION;

ANIMALS; CHONDROITIN SULFATES; COLLAGEN; DERMATAN SULFATE; EPITOPES, B-LYMPHOCYTE; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCOPROTEINS; GLYCOSAMINOGLYCANS; INTERVERTEBRAL DISK; KERATAN SULFATE; PROTEOGLYCANS; RATS; RATS, WISTAR;

EID: 0035040548     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(01)00125-1     Document Type: Article

References (78)

1. Regulation of development and differentiation by the extracellular matrix
2. Extracellular matrix of central nervous system white matter: demonstration of a hyaluronate-protein complex
3. On the existence of a cartilage-like proteoglycan and link proteins in the central nervous system
4. Collagen II is essential for the removal of the notochord and the formation of intervertebral discs
5. Biochemistry of the intervertebral disc
6. The Cell and Developmental Biology of tendons and ligaments
7. The mechanism of formation of bony spurs (enthesophytes) in the Achilles tendon
8. Time-dependent pericellular expression of collagen type IV, laminin and heparin sulphate proteoglycan in myofibroblasts
9. Cartilage fibronectin isoforms: in search of functions for a special population of matrix glycoproteins
10. Identification of a monoclonal antibody that specifically recognises corneal and skeletal keratan sulphate
11. Production and characterisation of monoclonal antibodies directed against connective tissue proteoglycans
12. Modulation of native chondroitin sulphate in tissue development and in disease
13. Immunological markers of cartilage proteoglycan metabolism in animal and human osteoarthritis
14. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican
15. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues
16. Identification of the N-linked oligosaccharide sites in chick corneal lumican and keratocan that receive keratan sulphate
17. Identification and immunolocalization of laminin in cartilage
18. Collagens of the disc
19. Biochemistry of the intervertebral disc
20. Types I and II collagens in human intervertebral disc. Interchanging radial distributions in annulus fibrosus
21. Quantitative analysis of types I and II collagens in human intervertebral disc at various ages
22. Monoclonal antibodies to type IV collagen: probes for the study and function of basement membranes
23. Characterisation and isolation of polyclonal and monoclonal antibodies against collagen for use in immunohistochemistry
24. Localisation of extracellular matrix components in the embryonic human notochord and axial mesenchyme
25. Current concepts of basement membrane structure and function
26. Hyaluronic acid in cartilage and proteoglycan aggregation
27. The role of link protein in the structure of cartilage aggregates
28. Notochord of chick embryos secretes short-form of type IX collagen prior to the onset of veterbral chondorgenesis
29. Role of actin stress fibres in the development of the intervertebral disc: cytoskeletal control of extracellular matrix assembly
30. Interaction of a 59-kDa connective tissue matrix proteoglycan with collagen I and collagen II
31. Binding of fibromodulin and decorin to separate sites on fibrillar collagens
32. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor-β
33. Characterisation of the antibody response in mice with type II collagen induced arthritis using monoclonal anti type II antibodies
34. Disc structure and function
35. Fibronectins: multifunctional modular glycoproteins
36. Relative increase of biglycan and decorin and altered CS epitopes in the degenerating human intervertebral disc
37. The occurrence of versican in the human intervertebral disc
38. Collagen synthesis and types I, III, IV, and VI in an animal model of disc degeneration
39. Widepread distribution of type II collagen during embryonic chick development
40. Expression pattern of type II collagen mRNA during early vertebral development in the human embryo
41. Type III collagen is crucial for collagen fibrillogenesis and for normal cardiovascular development
42. Proteoglycans of the intervertebral disc
43. Proteoglycan heterogeneity in the normal adult ovine intervertebral disc
44. Immunohistologic markers for age-related changes of human lumbar intervertebral discs
45. Biochemistry of the intervertebral disc
46. Immunological analysis of chick notochord and cartilage matrix development with antisera to cartilage matrix molecules
47. Observations on the pre-natal development of the intervertebral disc in man
48. Observations on the post-natal structure of the intervertebral disc in man
49. Spatial and temporal changes in the distribution of proteoglycans during avian neural crest development
50. Collagens in avian neural crest development: distribution in vivo and migration promoting ability in vitro
51. Identification of the keratan sulphate attachment sites on bovine fibromodulin
52. The extracellular matrix during neural crest formation and migration in rat embryos
53. Fibronectin structure and assembly
54. Type III collagen in the intervertebral disc
55. Proteoglycan components of the intervertebral disc and cartilage end-plate - an immunolocalisation study of animal and human tissues
56. Cartilage proteoglycans: structure and potential functions
57. Turnover rates of different collagen types measured by isotope ratio mass-spectrometry
58. The development of fibrocartilage in the rat intervertebral disc
59. In situ expression of collagen and proteoglycan genes in notochord and during skeletal development and growth
60. Basement membrane: putting up the barrier
61. Molecular heterogeneity of laminin and collagen IV at the neuromuscular junction and elsewhere
62. Identification of monoclonal antibodies that recognise novel epitopes in native chondroitin/dermatan sulphate glycosaminoglycan chains: their use in mapping functionally distinct domains of human skin
63. The chemical morphology of age-related changes in human intervertebral disc glycosaminoglycans from cervical, thoracic and lumbar nucleus pulposus and annulus fibrosus
64. Structure and function of basement membranes
65. Fibromodulin-null mice have abnormal collagen fibrils, tissue organisation, and altered lumican deposition in tendon
66. Localisation of type II collagen, long from of α1 (IX) collagen, and short form α1(IX) collagen transcripts in the developing chick notochord and axial skeleton
67. Supramolecular assembly of basement membranes
68. Collagenous and basement membrane proteins of chordoma: immunohistochemical analysis
69. Characterisation of a type IV collagen major cell binding site with affinity to the α1β1 and α2β1 integrins
70. Absence of keratan sulphate from skeletal tissues of mouse and rat
71. Immunohistochemical study of the biological fate of subcutaneous bovine collagen implant in rat
72. The development and growth of the intervertebral disc
73. Characterisation of collagens and proteoglycans at the insertion of the human Achilles tendon
74. Characterisation of breast stromal fibroblasts: cell surface distribution of collagen type IV, laminin and fibronectin
75. Promotion of chondrocyte proliferation by versican mediated G1 domain and EGF-like motifs
76. The G3 domain of versican inhibits mesenchymal chondrogenesis via the epidermal growth factor-like motifs